New Hampshire adopts retail tech to prevent illegal sales of pseudoephedrine
New Hampshire has adopted the real-time, stop-sale National Precursor Log Exchange technology, becoming the 35th state to adopt the system used by retailers across the country to help prevent the illegal sale of pseudoephedrine.
The legislation was signed Thursday by Gov. Chris Sununu in Lanconia, N.H., at Lakes Regional Hospital.
NPLEx has proven to be a useful tool in the fight against PSE diversion across the country. The system helps to prevent purchases by potential meth criminals while also protecting access to these safe and effective medicines for law-abiding consumers, including Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed. New Hampshire joins neighboring states Vermont and Maine, which adopted the system in previous years.
Aside from blocking illegal sales right at the pharmacy counter, the NPLEx system provides law enforcement with valuable, real-time data on potential criminal activity.
"We are committed to continue reducing the local methamphetamine production problem using solutions that are proven to work,” said New Hampshire State Senator, Sharon Carson. “The adoption of NPLEx here in New Hampshire shows our commitment, and it gives law enforcement and pharmacists – those serving on the front line – new tools and resources to help curb meth production in our state, while also protecting law-abiding citizens' access to the medicines they need.”
The announcement comes after a recent report from the National Association of Drug Diversion Investigators showing that, so far nationwide in 2018, between Jan. 1 and Mach 31, NPLEx has blocked the illegal sale of 226,670 boxes of medicine containing PSE, keeping 786,753 grams of PSE out of the hands of potential criminals.”